Deerfield Management Company, L.P. (Series C) Newamsterdam Pharma CO Nv Wt E Call Options Transaction History

Deerfield Management Company, L.P. (Series C)

$4.76 Billion
Q2 2024

Call Options

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

Others Institutions Holding NAMSW

# of Institutions

Shares Held

1.29M

Call Options Held

75K

Put Options Held

Frazier Life Sciences Management, L.P. Menlo Park, CA

500K
Shares

$0
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

333K
Shares

$0
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

203K
Shares

$0
0.0% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

100K
Shares

$0
0.0% of portfolio
Hrt Financial LP New York, NY

30.3K
Shares

$0
0.0% of portfolio

View Full List

About NEWAMSTERDAM PHARMA CO NV WT E

Ticker NAMSW

More about NAMSW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account